CinCor Pharma, Inc.
CINCNASDAQHealthcare
$29.06
+$0.00(+0.00%)
Market Cap$1.3B
P/E Ratio—
52W High$43.15
52W Low$10.53
CinCor Pharma, Inc. (CINC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CINC · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|
| Revenue | |||
| Revenue | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — | — |
| Operating Expenses | |||
| R&D Expenses | $0.02B | $0.02B | $0.00B |
| G&A Expenses | $0.02B | $0.00B | $0.00B |
| Total Operating Expenses | $0.04B | $0.02B | $0.01B |
| Operating Income | ($0.04B) | ($0.02B) | ($0.01B) |
| Operating Margin %(computed) | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.05B) | ($0.02B) | ($0.01B) |
| Income Tax Expense | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Income | ($0.05B) | ($0.02B) | ($0.00B) |
| Net Margin %(computed) | — | — | — |
| Per Share & EBITDA | |||
| EPS (Basic) | $-1.42 | $-0.95 | $-0.21 |
| Wtd Avg Shares | 0.04B | 0.02B | 0.02B |
| EBITDA | ($0.03B) | ($0.02B) | ($0.01B) |
| EBITDA Margin %(computed) | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more CinCor Pharma, Inc. data
About CinCor Pharma, Inc. (CINC) Income Statement
CinCor Pharma, Inc. (CINC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2021, CINC reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.05B) — a net profit margin of —.
Frequently asked questions
CINC · 4 questionsCinCor Pharma, Inc. (CINC) reported revenue of $0.00B for 2021, down —% year-over-year.
CINC revenueCINC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08